Deterministic and probabilistic acute-based environmental risk assessment for naproxen for Western Europe

Environmental Toxicology and Chemistry

Volumn 26, Issue 4, 2007, Pages 795-806

  Straub, Jürg Oliver ^a   Stewart, Kathleen M ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Deterministic; Environmental risk assessment; Naproxen; Probabilistic

Indexed keywords

ECOSYSTEMS; ENVIRONMENTAL IMPACT; PROBABILISTIC LOGICS; SURFACE WATERS; TOXICITY;

DETERMINISTIC; ECOTOXICITY; ENVIRONMENTAL RISK ASSESSMENT; NAPROXEN;

RISK ASSESSMENT;

NAPROXEN; SURFACE WATER;

CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; EUROPEAN UNION; MEASUREMENT METHOD; POLLUTION EXPOSURE; PROBABILITY; RISK ASSESSMENT; SURFACE WATER; TOXICITY;

ARTICLE; BIODEGRADABILITY; DRUG SCREENING; DRUG USE; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RISK ASSESSMENT; SEWAGE TREATMENT;

ENVIRONMENT; ENVIRONMENTAL MONITORING; EUROPE; NAPROXEN; RISK ASSESSMENT; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL;

EURASIA; EUROPE; WESTERN EUROPE;

EID: 34247509114     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/06-212R.1     Document Type: Article

References (59)

1. American Chemical Society. 2003. SciFinder Database online. Washington, DC.
2. Hradman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A. 1996. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York, NY, USA.
3. Beers MH. 2004. The Merck Manual of Medical Information, 2nd ed. Merck, Whitehouse Station, NJ, USA.
4. Miners JO, Coulter S, Tukey RH, Veronese ME, Birkett DJ. 1996. Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen. Biochem Pharmacol 51:1003-1008.
5. IMS Health. 2005. Naproxen and naproxen salts sales data for western Europe and North America/1995-2004. Copyright 2004, reprinted with permission. All rights reserved.
6. Organization for Economic Cooperation and Development. 1984. Guidelines for testing of chemicals. Section 2: Effects on biotic systems, alga, growth inhibition test. Guideline 201. Paris, France.
7. American Society for Testing and Materials. 2001. Standard guide for conducting acute toxicity tests with fishes, macroinvertebrates, and amphibians. E 729-96. In Annual Book of ASTM Standards. Vol 11.05. Philadelphia, PA, pp 175-196.
8. Elendt BP, Bias WR. 1990. Trace nutrient deficiency in Daphnia magna cultured in standard medium for toxicity testing. Effects of the optimization of culture conditions on life history parameters of D. magna. Water Res 24:1157-1167.
9. Organization for Economic Cooperation and Development. 1992. Guidelines for testing of chemicals. Section 2: Effects on biotic systems, fish, acute toxicity test. Guideline 203. Paris, France.
10. European Medicines Evaluation Authority. 2005. Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. EMEA/CHMP/SWP/4447/00. London, UK.
11. European Chemicals Bureau. 2005. European Union System for the Evaluation of Substances (EUSES), Ver 2.0. European Chemicals Bureau, Ispra, Italy.
12. European Commission. 2003. Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances, Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Brussels, Belgium.
13. Advanced Chemistry Development. 1997. Results of titrometric and shake-flask measurements on selected drugs compared to ACD/logD predictions. ACD/logD Suite. Toronto, ON, Canada.
14. Avdeef A, Berger CM, Brownell C. 2000. pH-Metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharmacol Res 17:85-89.
15. Cunningham VL. 2004. Special characteristics of pharmaceuticals related to environmental fate. In Kümmerer K, ed, Pharmaceuticals in the Environment: Sources, Fate, Effects, and Risks, 2nd ed. Springer, Berlin, Germany, pp 13-24.
16. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3260.
17. Joss A, Carballa M, Kreuzinger N, Siegrist H, Zabczynski S. 2006. Wastewater Treatment. In Ternes T, Joss A, eds, Human Pharmaceuticals, Hormones, and Fragrances: The Challenge of Micropollutants in Urban Water Management. IWA, London, UK, pp 243-292.
18. Ternes TA. 2000. Rückstände von Arzneimitteln, Diagnostika und Antiseptika in Abwasser, Flüssen und Grundwasser. Eine neue Herausforderung für die Wasserwirtschaft. Habilitationsschrift, Universität Mainz, Mainz, Germany.
19. Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez M, Ternes T. 2004. Behavior of pharmaceuticals, cosmetics, and hormones in a sewage treatment plant. Water Res 38:2918-2926.
20. Stumpf M, Ternes TA, Wilken R-D, Vianna Rodrigues S, Baumann W. 1999. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135-141.
21. Thomas PT, Foster GD. 2005. Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process. Environ Toxicol Chem 24:25-30.
22. Tixier C, Singer HP, Oellers J, Müller SR. 2003. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37:1061-1068.
23. Central Intelligence Agency. 2005. The World Factbook 2005. Washington, DC.
24. European Framework for Probabilistic Risk Assessment of the Environmental Impacts of Pesticides. 2005. Introducing probabilistic methods into the ecological risk assessment of pesticides. Draft EUFRAM Report, Vol 1, Ver 6. Central Science Laboratory, York, UK.
25. Wiegel S, Aulinger A, Brockmeyer R, Harms H, Löffler J, Reincke H, Schmidt R, Stachel B, von Tümpling W, Wanke A. 2004. Pharmaceuticals in the River Elbe and its tributaries. Chemosphere 57:107-126.
26. Stumpf M, Ternes TA, Haberer K, Baumann W. 1998. Isolation of ibuprofen-metabolites and their importance as pollutants of the aquatic environment. Vom Wasser 91:291-303.
27. Amt für Umwelt und Energie Basel-Stadt. 2005. Monatsberichte, Rheinüberwachungsstation Weil am Rhein. Jan 2003 to May 2005. Basel, Switzerland.
28. Degim T, Zaimoglu V, Akay C, Degim Z. 2001. pH-Metric logK calculations of famotidine, naproxen, nizatidine, ranitidine, and salicylic acid. Il Farmaco 56:659-663.
29. Canadian Environmental Modeling Center. 2002. Level III, Fugacity-Based Multimedia Environmental Model, Ver 2.70. Trent University, Peterborough, ON.
30. Richardson ML, Bowron JM. 1985. The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 37:1-12.
31. Boethling RS, Lynch DG, Jaworska JS, Tunkel JL, Thom GC, Webb S. 2004. Using BioWin™, Bayes, and batteries to predict ready biodegradability. Environ Toxicol Chem 23:911-920.
32. Marchese S, Perret D, Gentili A, Curini R, Pastori F. 2003. Determination of nonsteroidal anti-inflammatory drugs in surface water and wastewater by liquid chromatography-tandem mass spectrometry. Chromatographia 58:263-269.
33. Zuccato E, Bagnati R, Fioretti F, Natangelo M, Calamari D, Fanelli R. 2001. Environmental loads and detection of pharmaceuticals in Italy. In Kümmerer K, ed, Pharmaceuticals in the Environment; Sources, Fate, Effects, and Risks, 1st ed. Springer, Berlin, Germany, pp 19-27.
34. Boreen AL, Arnold WA, McNeill K. 2003. Photodegradation of pharmaceuticals in the aquatic environment. Aquat Sci 65:320-341.
35. Gross B, Montgomery-Brown J, Naumann A, Reinhard M. 2004. Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent-dominated river and wetland. Environ Toxicol Chem 23:2074-2083.
36. Ternes TA, Stumpf M, Schuppert B, Haberer K. 1998. Simultane Bestimmung von Antiseptika and sauren Pharmaka in Abwasser und Fliessgewässern. Vom Wasser 90:295-309.
37. Bund/Länderausschuss für Chemikaliensicherheit. 2003. Arzneimittel in der Umwelt. Auswertung der Untersuchungsergebnisse, Bericht an die 61. Umwelt-minister-konferenz. Hamburg, Germany.
38. Donovan JL, Blake DR. 1992. Patient noncompliance: Deviance or reasoned decision making? Soc Sci Med 34:507-513.
39. Kuspis DA, Krenzelok EP. 1996. What happens to expired medications? A survey of community medication disposal. Vet Hum Toxicol 38:48-49.
40. Packer JL, Werner JJ, Latch DE, McNeill K, Arnold WA. 2003. Photochemical fate of pharmaceuticals in the environment: Naproxen, diclofenac, clofibric acid, and ibuprofen. Aquat Sci 65:342-351.
41. Commission of the European Communities. 1992. Council Directive 92/32/EEC of 30 April 1992 amending for the seventh time Directive 67/548/EEC on the approximation of the laws, regulations, and administrative provisions relating to the classification, packaging, and labeling of dangerous substances. Official Journal of the European Union L154(05/06/1992):1-29.
42. Eberius M, Mennicken G, Reuter I, Vandenhirtz J. 2002. Sensitivity of different growth inhibition tests - just a question of mathematical calculation? Theory and practice for algae and duckweed. Ecotoxicology 11:293-297.
43. Klimisch HJ, Andreae E, Tillmann U. 1997. A systematic approach for evaluating the quality of experimental and ecotoxicological data. Regul Toxicol Pharmacol 25:1-5.
44. Organization for Economic Co-Operation and Development. 2005. Manual for Investigation of HPV Chemicals; Chapter 3: Data evaluation. OECD, Paris, France. pp 1-111.
45. Escher BI, Bramaz N, Richter M, Lienert J. 2006. Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environ Sci Technol 40:7402-7408.
46. U.S. Environmental Protection Agency. 2004. EPISuite, Ver 3.12. Syracuse Research Center, Syracuse, NY.
47. Isidori M, Lavorgna M, Nardelli A, Parelly A, Previtera L, Rubino M. 2005. Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 348:91-101.
48. University of Georgia. 2004. SPARC On-Line Calculator. Atlanta, GA, USA.
49. Chowhan ZT. 1978. pH-Solubility profiles of organic carboxylic acids and their salts. J Pharm Sci 67:1257-1260.
50. Avdeef A, Berger CM, Brownell C. 2000. pH-Metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility pH methods. Pharm Res 17:85-89.
51. Scott DC, Clymer JW. 2002. Estimation of distribution coefficients from the partition coefficient and pKa. Pharm Technol Nov 2002:30-40.
52. Perlovich GL, Kurkov SV, Kinchin AN, Bauer-Brandl A. 2004. Solvation and hydration characteristics of ibuprofen and acetylsalicylic acid. AAPS Pharm Sci 6:1-9.
53. Zhu C, Jiang L, Chen TM, Hwang KK. 2002. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur J Med Chem 37:399-407.
54. Cartella M, Omil F, Lema JM, Ternes TA. 2003. Fate of PPCPs during anaerobic treatment of sewage sludge. Abstracts, POSEIDON Symposium, November 4-5, Braunschweig, Germany, European Commission, Brussels, Belgium, p 26.
55. Botsford J. 2002. A comparison of ecotoxicological tests. ATLA 30:539-550.
56. Cleuvers M. 2004. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 59:309-315.
57. Cleuvers M. 2003. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185-194.
58. Rodriguez C, Chellman K, Gomez S, Marple L. 1992. Environmental assessment report pursuant to 21 CFR 25.31(a) submitted to the US FDA in support of the new drug application (NDA) for naproxen for over-the-counter use. Hamilton Pharmaceuticals, Puerto Rico; as cited by Webb SF. 2001. A data-based perspective on the environmental risk assessment of human pharmaceuticals. I - Collation of available ecotoxicity data. In Kümmerer K, ed, Pharmaceuticals in the Environment; Sources, Fate, Effects and Risks, 1st ed. Springer, Berlin, Germany, pp 175-201.
59. DellaGreca M, Brigante M, Isidori M, Nardelli A, Previtera L, Rubino M, Temussi F. 2004. Phototransformation and ecotoxicity of the drug naproxen-Na. Environ Chem Lett 1:237-241.